Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Microphthalmia, Isolated, with Coloboma 5 1Medulloblastoma 1

Interventions

Vincristine 9Cyclophosphamide 8Cisplatin 7Radiotherapy 6Platinum 51,2-diaminocyclohexaneplatinum II citrate 5Radiation 4Lomustine 4Filgrastim 4Etoposide 4Carboplatin 4Magnetic Resonance Spectroscopy 3Irinotecan 3Granulocyte Colony-Stimulating Factor 3sodium thiosulfate 2merphos 2Temozolomide 2Specimen Handling 2Psychiatric Rehabilitation 2Methotrexate 2sonidegib 1silmitasertib 1sargramostim 1ribociclib 1palbociclib 1omburtamab I-131 1lonafarnib 1laromustine 1emvododstat 1azurin (50-77) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Medulloblastoma × silmitasertib × Clear all
NCT03904862 2025-10-30

Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery

Pediatric Brain Tumor Consortium

Phase 1/2 Terminated
21 enrolled
CNS

Microphthalmia, Isolated, with Coloboma 5, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡